Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial

Boubacar Coulibaly, Augustin Zoungrana, Frank P. Mockenhaupt et al. · 2009

Read Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial by Boubacar Coulibaly, Augustin Zoungrana, Frank P. Mockenhaupt et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005318.txt.

Description

Controlling malaria means not only curing patients but also stopping spread to mosquitoes. Drugs that kill the parasite's sexual stages, called gametocytes, can break transmission. Coulibaly and colleagues ran a randomized controlled trial of a methylene blue combination therapy in PLOS ONE in 2009.

Methylene blue is an old, blue-dyed drug with activity against malaria parasites. The trial found a strong gametocytocidal effect, as the title states, against falciparum malaria. A transmission-blocking treatment like this could support local elimination of malaria, not just treatment of the sick. A drug that stops spread, not just cures the sick, could help a town clear malaria for good. Since each cured case would no longer seed new ones by mosquito bite.

Catalog record

CREATORBoubacar Coulibaly, Augustin Zoungrana, Frank P. Mockenhaupt et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005318

Browse the full library · About the Tower of Babel